Skip to main content
OpenTrials

Clinical trial condition

Metastatic Solid Tumor

Explore clinical trials studying Metastatic Solid Tumor. Study availability and eligibility vary by location and protocol.

82 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Solid Tumor trial results

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

NCT06952010

Conditions
Advanced Solid Tumor, Immune Sensitive Tumor, Metastatic Solid Tumor, +6 more
Locations
  • Exelixis Clinical Site #5 San Francisco, California, United States
  • Exelixis Clinical Site #4 New Haven, Connecticut, United States
  • Exelixis Clinical Site #8 Tampa, Florida, United States
  • Exelixis Clinical Site #10 Boston, Massachusetts, United States
View Trial Details
Recruiting

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

NCT07638371

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +7 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

NCT05384626

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 74 locations
View Trial Details

Related conditions